Cas:886774-09-0 tert-butyl 3-[[4-(trifluoromethoxy)phenyl]methyl]piperazine-1-carboxylate manufacturer & supplier

We serve Chemical Name:tert-butyl 3-[[4-(trifluoromethoxy)phenyl]methyl]piperazine-1-carboxylate CAS:886774-09-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-butyl 3-[[4-(trifluoromethoxy)phenyl]methyl]piperazine-1-carboxylate

Chemical Name:tert-butyl 3-[[4-(trifluoromethoxy)phenyl]methyl]piperazine-1-carboxylate
CAS.NO:886774-09-0
Synonyms:1-piperazinecarboxylic acid,3-[[4-(trifluoromethoxy)phenyl]methyl]-,1,1-dimethylethyl ester;3-(4-trifluoromethoxy-benzyl)-piperazine-1-carboxylic acid tert-butyl ester
Molecular Formula:C17H23F3N2O3
Molecular Weight:360.37100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:50.80000
Exact Mass:360.16600
LogP:3.60330

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-piperazinecarboxylic acid,3-[[4-(trifluoromethoxy)phenyl]methyl]-,1,1-dimethylethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(4-trifluoromethoxy-benzyl)-piperazine-1-carboxylic acid tert-butyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-piperazinecarboxylic acid,3-[[4-(trifluoromethoxy)phenyl]methyl]-,1,1-dimethylethyl ester Use and application,1-piperazinecarboxylic acid,3-[[4-(trifluoromethoxy)phenyl]methyl]-,1,1-dimethylethyl ester technical grade,usp/ep/jp grade.


Related News: Just last week, the CDC updated J&J’s label again to warn of “an increased risk” for GBS, although the agency has maintained that a definitive link hasn’t been established. Europe’s medicines regulator added its own warning on Thursday just ahead of ACIP’s meeting. 3-(phenylmethoxycarbonylamino)-3-piperidin-3-ylpropanoic acid manufacturers The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. 3-Oxo-3-[3-(trifluoromethyl)phenyl]propanenitrile suppliers The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above, EMA said. 1-acetyl-2,3-dihydroindole-5-sulfonyl chloride vendor & factory.